The legal fight over mifepristone entered yet another volatile phase late last week when the Supreme Court restored telehealth prescribing and mail delivery of the abortion and miscarriage medication. Here's how to tell the story. healthjournalism.org/blog/2026/05...
The court's decision to block telehealth prescribing of mifepristone signals ongoing instability in how a widely used, evidence-based medication is regulated and delivered in the United States.